Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. N. Anokhina, E. K. Anaev, A. I. Revelsky, A. A. Rodionov, I. A. Revelsky, V. B. Kudriavtsev, A. G. Chuchalin (Moscow, Russian Federation). Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD. Eur Respir J 2009; 34: Suppl. 53, 4555

Member's Comments

No comment yet.

Related content which might interest you: Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Metabonomics applied to exhaled breath condensate in childhood asthma Source: Eur Respir J 2006; 28: Suppl. 50, 123s Year: 2006 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017 Year: 2018 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006 The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes. Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011 Detection and characterisation of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients Source: Eur Respir J, 58 (2) 2003024; 10.1183/13993003.03024-2020 Year: 2021 NMR-based metabolomics of exhaled breath condensate for assessing the effects of inhaled corticosteroids in COPD patients Source: International Congress 2017 – Management of COPD Year: 2017 Is the analysis of torbamycin in exhaled breath condensate a diagnostic tool to monitor pulmonary drug deposition? Source: Eur Respir J 2004; 24: Suppl. 48, 386s Year: 2004 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Limited clinical value of exhaled volatile organic compound measurements in childhood asthma Source: ERJ Open Res, 4 (4) 00026-2018; 10.1183/23120541.00026-2018 Year: 2018 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006